JP2023549433A5 - - Google Patents
Info
- Publication number
- JP2023549433A5 JP2023549433A5 JP2023547921A JP2023547921A JP2023549433A5 JP 2023549433 A5 JP2023549433 A5 JP 2023549433A5 JP 2023547921 A JP2023547921 A JP 2023547921A JP 2023547921 A JP2023547921 A JP 2023547921A JP 2023549433 A5 JP2023549433 A5 JP 2023549433A5
- Authority
- JP
- Japan
- Prior art keywords
- pna oligomer
- hybridization probe
- group
- probe portion
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE2051204 | 2020-10-16 | ||
| SE2051204-2 | 2020-10-16 | ||
| PCT/EP2021/078854 WO2022079321A1 (en) | 2020-10-16 | 2021-10-18 | Pna probes for pretargeted imaging and therapy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023549433A JP2023549433A (ja) | 2023-11-24 |
| JP2023549433A5 true JP2023549433A5 (enExample) | 2024-10-23 |
| JP7795810B2 JP7795810B2 (ja) | 2026-01-08 |
Family
ID=78463448
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023547921A Active JP7795810B2 (ja) | 2020-10-16 | 2021-10-18 | プレターゲットイメージングおよび治療用ｐｎａプローブ |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240148917A1 (enExample) |
| EP (1) | EP4228763A1 (enExample) |
| JP (1) | JP7795810B2 (enExample) |
| KR (1) | KR20230088731A (enExample) |
| CN (1) | CN116322784A (enExample) |
| CA (1) | CA3195446A1 (enExample) |
| WO (1) | WO2022079321A1 (enExample) |
| ZA (1) | ZA202304592B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11180531B2 (en) | 2018-06-22 | 2021-11-23 | Bicycletx Limited | Bicyclic peptide ligands specific for Nectin-4 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11507046A (ja) | 1995-06-07 | 1999-06-22 | イムノメディクス，インコーポレイテッド | 診断剤および治療剤の標的部位への改良された送達方法 |
| CA2531238C (en) | 2003-07-04 | 2015-02-24 | Affibody Ab | Polypeptides having binding affinity for her2 |
| US20050260131A1 (en) * | 2004-05-20 | 2005-11-24 | General Electric Company | Pharmaceuticals for enhanced delivery to disease targets |
| EP1920072A2 (en) * | 2005-07-01 | 2008-05-14 | Dako Denmark A/S | In situ hybridization detection method |
| EP3087182B1 (en) * | 2013-12-23 | 2019-03-20 | Memorial Sloan-Kettering Cancer Center | Methods and compositions for treating cancer using peptide nucleic acid-based agents |
| WO2018118759A1 (en) * | 2016-12-19 | 2018-06-28 | Ventana Medical Systems, Inc. | Peptide nucleic acid conjugates |
-
2021
- 2021-10-18 JP JP2023547921A patent/JP7795810B2/ja active Active
- 2021-10-18 CA CA3195446A patent/CA3195446A1/en active Pending
- 2021-10-18 WO PCT/EP2021/078854 patent/WO2022079321A1/en not_active Ceased
- 2021-10-18 US US18/249,192 patent/US20240148917A1/en active Pending
- 2021-10-18 EP EP21801030.4A patent/EP4228763A1/en active Pending
- 2021-10-18 CN CN202180070724.1A patent/CN116322784A/zh active Pending
- 2021-10-18 KR KR1020237014051A patent/KR20230088731A/ko active Pending
-
2023
- 2023-04-20 ZA ZA2023/04592A patent/ZA202304592B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7016975B2 (ja) | ナノ粒子イムノコンジュゲート | |
| US8865873B2 (en) | Internalizing human monoclonal antibodies targeting prostate cancer cells in situ | |
| JP6257669B2 (ja) | ヒト前立腺特異的膜抗原（ｐｓｍａ）をターゲッティングするｊ５９１ミニボディおよびｃｙｓダイアボディならびにこれらを使用するための方法 | |
| JP2009531324A5 (enExample) | ||
| TWI259837B (en) | Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis | |
| JP5110768B2 (ja) | モノクローナル抗体ｐａｍ４ならびに膵臓癌の診断および治療のためのその使用 | |
| EP1781818B1 (en) | CANCER AND INFLAMMATION DIAGNOSIS USING ANTI sTNFR ANTIBODIES | |
| Gong et al. | A 3E8. scFv. Cys-IR800 conjugate targeting TAG-72 in an orthotopic colorectal cancer model | |
| JP2009280607A (ja) | フィブロネクチンのｅｄ−ｂドメインに対する抗体、それを含有する抱合体、および、腫瘍および血管新生関連の疾病の診断および治療をするためのそれの用途 | |
| US9718888B2 (en) | Methods and compositions related to single chain antibody fragments that bind to tumor-associated glycoprotein 72 (TAG-72) | |
| JP2006513695A5 (enExample) | ||
| TWI780082B (zh) | 新穎抗人類ＭＵＣ１抗體Ｆａｂ片段 | |
| CN117327182B (zh) | Cldn18.2单域抗体探针的制备方法及应用 | |
| Casey et al. | Tumour targeting of humanised cross-linked divalent-Fab′ antibody fragments: a clinical phase I/II study | |
| Khawli et al. | Comparison of recombinant derivatives of chimeric TNT-3 antibody for the radioimaging of solid tumors | |
| CA2956161A1 (en) | Methods and compositions related to antibody fragments that bind to tumor-associated glycoprotein 72 (tag-72) | |
| JP2020513817A (ja) | ヒトｆｓｈｒ細胞外ドメインに対する抗体 | |
| CN103582497A (zh) | 用于成像的基于聚苹果酸的纳米缀合物 | |
| Hagemans et al. | Multiscale imaging of therapeutic anti-PD-L1 antibody localization using molecularly defined imaging agents | |
| E. Wang et al. | Antibody-based imaging of HER-2: moving into the clinic | |
| JP7708374B2 (ja) | フィブリンに結合する抗体および当該抗体を含む医薬組成物 | |
| Ding et al. | Development of gold nanorods conjugated with radiolabeled anti-human epidermal growth factor receptor 2 (HER2) monoclonal antibody as single-photon emission computed tomography/photoacoustic dual-imaging probes targeting HER2-positive tumors | |
| JP2022541765A (ja) | 抗ｇｒｐ７８抗体およびその使用方法 | |
| WO2012032043A1 (en) | 212 pb imaging | |
| US11666672B2 (en) | Anti-CD33 antibody-guided imaging and treatment of acute myeloid leukemia |